Tucker Asset Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-100
Closed -$2.88K 1202
2022
Q4
$2.88K Hold
100
﹤0.01% 514
2022
Q3
$2.9K Hold
100
﹤0.01% 516
2022
Q2
$3.39K Buy
+100
New +$3.58K ﹤0.01% 388

Other funds holding IRMD

Tucker Asset Management's IRMD Position: Q1 2023 in Review

Tucker Asset Management sold out of iRadimed (IRMD) in Q1 2023, closing a stake of 100 shares — an estimated $2.88K sold.

Tucker Asset Management first reported a position in IRMD in Q2 2022 and held it in 3 quarters. The position peaked at $3.39K in Q2 2022. 89 funds tracked by Wall St. Rank hold IRMD as of Q1 2023.

  • Tucker Asset Management reported no remaining iRadimed position as of Q1 2023 after selling out during the quarter.
  • Tucker Asset Management sold 100 iRadimed shares in Q1 2023, an estimated $2.88K.
  • Tucker Asset Management first reported a position in iRadimed in Q2 2022 and held it in 3 quarters.
  • Tucker Asset Management's iRadimed position peaked at $3.39K in Q2 2022.
  • 89 funds tracked by Wall St. Rank held iRadimed as of Q1 2023.

Based on Tucker Asset Management's 13F filing for Q1 2023, filed 11 May 2023.